高水平血管细胞黏附分子-1与系统性硬化症「血管病表型」相关且死亡率更高
基于澳大利亚硬皮病队列388例系统性硬化症(SSc)患者,按血清VCAM-1四分位分层,Q4组全因死亡率显著升高(HR 2.17,95%CI 1.54-3.04;P<0.001),且更常见肺动脉高压、SSc相关心肌病和指端溃疡,死因分析显示PAH、SSc相关心肌病及心血管病作为死因或 contributory 的比例更高,而间质性肺病存在、严重程度及死因无关。
要点
- SSc患者血清VCAM-1最高四分位组全因死亡率显著增高(HR 2.17)。
- Q4组肺动脉高压、SSc相关心肌病及指端溃疡更常见。
- Q4组PAH、SSc心肌病及心血管病死因风险分别升高(HR 3.08、2.85、2.50)。
核心结论
- SSc患者中血清VCAM-1最高四分位组死亡率增高,主要归因于血管病变表现频率增加。
- Q4组其他已知死亡风险因素频率未见不成比例增加,提示VCAM-1在疾病病理生理中可能独立起作用。
研究设计与样本
- 研究为澳大利亚硬皮病队列研究,共纳入388例SSc患者,87.1%为女性,76.8%为局限皮肤型,诊断时中位年龄45.7岁(IQR 36.4-56.7)。
- VCAM-1采用磁珠Luminex法测定,按四分位分层,数据与全国死亡索引链接进行死因特异性死亡分析,提取截至2024年2月。
主要发现
- Q4组与其他组相比全因死亡率升高(HR 2.17,95%CI 1.54-3.04;P<0.001)。
- VCAM-1各四分位组间性别、年龄、病程、疾病亚型、自身抗体谱及用力肺活量无统计学显著差异。
- Q4组更常见肺动脉高压(P=0.028)、SSc相关心肌病(P=0.009)及指端溃疡(P=0.003)。
- 死因分析中,Q4组PAH(HR 3.08,95%CI 1.68-5.65;P<0.001)、SSc相关心肌病(HR 2.85,95%CI 1.51-5.38;P=0.001)及全因心血管病(HR 2.50,95%CI 1.60-3.89;P<0.001)作为死因或 contributing 因素更常见。
- Q4组VCAM-1水平与间质性肺病存在、严重程度及死因特异性死亡无关联。
关键数值与推荐
- Q4组全因死亡风险HR 2.17(95%CI 1.54-3.04;P<0.001)。
- Q4组PAH作为死因或 contributing 因素的HR 3.08(95%CI 1.68-5.65;P<0.001)。
- Q4组SSc相关心肌病作为死因或 contributing 因素的HR 2.85(95%CI 1.51-5.38;P=0.001)。
- Q4组全因心血管病作为死因或 contributing 因素的HR 2.50(95%CI 1.60-3.89;P<0.001)。
临床怎么用
- 对SSc患者可考虑检测血清VCAM-1,Q4水平提示血管病变表型及死亡风险增高。
- VCAM-1 Q4患者应加强肺动脉高压、SSc相关心肌病及指端溃疡的筛查与监测。
局限性
- 研究为观察性队列设计,VCAM-1与结局的关联不能直接推断因果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine disease-specific associations of serum vascular cell adhesion molecule-1 (VCAM-1) and associated mortality in SSc. METHODS: Participants were identified from the Australian Scleroderma Cohort Study. Data were linked with the National Death Index for cause-specific mortality. VCAM-1 was measured using a magnetic Luminex assay. Participant characteristics and information on organ specific manifestations were extracted until February 2024. Participants were stratified into VCAM-1 quartiles. RESULTS: Of 388 participants, 87.1% were female and 76.8% had limited cutaneous disease. Median age at diagnosis was 45.7 years (interquartile range 36.4-56.7). Participants with upper quartile VCAM-1 (quartile 4; Q4) had increased mortality compared with others [hazard ratio (HR) 2.17, 95% CI 1.54-3.04; P < 0.001]. Despite the significant increased mortality in Q4, there were no statistically significant differences in sex, age, disease duration, disease subtype, autoantibody profile or forced vital capacity across the VCAM-1 quartiles. Q4 were more likely to have pulmonary arterial hypertension (PAH; P = 0.028), SSc-attributable myocardial disease (P = 0.009) and digital ulcers (P = 0.003). In cause-specific mortality analysis, Q4 were more likely to have PAH (HR 3.08, 95% CI 1.68-5.65; P < 0.001), SSc-attributable myocardial disease (HR 2.85, 95% CI 1.51-5.38; P = 0.001) and all-cause cardiovascular disease (HR 2.50, 95% CI 1.60-3.89; P < 0.001) listed as a cause or contributor to death. Q4 VCAM-1 level was not associated with interstitial lung disease presence, severity or cause-specific mortality. CONCLUSION: The increased mortality in participants with SSc and Q4 VCAM-1 levels is attributable to increased frequency of vascular disease manifestations. Q4 participants do not have a disproportionate frequency of other established risk factors for increased mortality, suggesting an independent role for VCAM-1 in disease pathophysiology.
引用
- Parker MJS, Nikpour M, Hansen D, et al. High levels of vascular cell adhesion molecule-1 associate with a 'vasculopathic' phenotype in systemic sclerosis with higher mortality. Rheumatology (Oxford). 2026. PMID: 42525382. doi:10.1093/rheumatology/keag391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。